SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Poulakou, M. V.
Right arrow Articles by Perrea, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poulakou, M. V.
Right arrow Articles by Perrea, D. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography

Maria V. Poulakou

Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece

Kosmas I. Paraskevas

Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Hospital and Royal Free University College Medical School, University College London, UK, Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece

Ioannis S. Vlachos

Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece

Sonia-Athena P. Karabina

INSERM U525, Faculté de Médecine Pitié-Salpetrière, Paris, France

Mark R. Wilson

School of Biological Sciences, University of Wollongong, NSW, Australia

Dimitrios C. Iliopoulos

Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece, Department of Cardiothoracic Surgery, "Athens Medical Center," Athens, Greece

Serafim I. Tsitsilonis

Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece

Dimitri P. Mikhailidis

Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Hospital and Royal Free University College Medical School, University College London, UK

Despina N. Perrea

Laboratory for Experimental Surgery and Surgical Research 'N. S. Christeas,' School of Medicine, National and Kapodistrian University of Athens, Greece, dperrea{at}med.uoa.gr

It has been proposed that apolipoprotein J (apo J) and paraoxonase-1 (PON1) correlate with the extent and severity of ischemic heart disease (IHD). This article compares apo J and PON1 serum concentrations, PON1 activity, and the apo J/PON1 ratio in 138 IHD patients (64 statins users and 74 statin nonusers) referred for angiography and possible percutaneous coronary intervention. The effect of statin treatment on apo J and PON1 concentrations, PON1 activity, and the degree of coronary artery stenosis were evaluated. In both groups, apo J levels were increased, whereas PON1 concentration and activity decreased. IHD patients on statins had significantly lower apo J concentration and higher PON1 concentration and activity. Patients on statins had less coronary artery stenosis. High apo J levels, low PON1 levels, low PON1 activity, and a high apo J/PON1 ratio were associated with IHD. Statin treatment reverses these changes, probably by multiple beneficial actions.

Key Words: apolipoprotein J • ischemic heart disease • paraoxonase-1 • statins

Angiology, Vol. 59, No. 2, 137-144 (2008)
DOI: 10.1177/0003319707311722


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
A. Gluba, T. Pietrucha, M. Banach, G. Piotrowski, and J. Rysz
The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study
Angiology, February 1, 2010; 61(2): 157 - 165.
[Abstract] [PDF]


Home page
J. Nutr.Home page
K. B. Holven, P. Aukrust, K. Retterstol, K. Otterdal, V. Bjerkeli, L. Ose, M. S. Nenseter, and B. Halvorsen
The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects
J. Nutr., November 1, 2008; 138(11): 2070 - 2075.
[Abstract] [Full Text] [PDF]



Advertisement